Filing Details
- Accession Number:
- 0001209191-23-055948
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-20 10:07:28
- Reporting Period:
- 2023-11-16
- Accepted Time:
- 2023-11-20 10:07:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
818033 | Heron Therapeutics Inc. | HRTX | Pharmaceutical Preparations (2834) | 942875566 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1314760 | P William Forbes | 4242 Campus Point Court, Suite 200 San Diego CA 92121 | Evp, Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-11-16 | 50,000 | $0.94 | 54,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The range of purchase prices paid was $0.9348 to $0.94. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased at each separate price.